eMedicine Specialties > Pediatrics: Cardiac Disease and Critical Care Medicine > Critical Care

Acidosis, Metabolic

Author: Margaret A Priestley, MD, Assistant Professor of Clinical Anesthesiology and Critical Care, University of Pennsylvania School of Medicine; Clinical Director, Pediatric Intensive Care Unit, The Children's Hospital of Philadelphia
Contributor Information and Disclosures

Updated: Jun 25, 2009

Introduction

Background

A metabolic acidosis is an acid-base disorder characterized by a decrease in serum pH that results from either a primary decrease in plasma bicarbonate concentration ([HCO3 -]) or an increase in hydrogen ion concentration ([H+]). It is not a disease but rather a biochemical abnormality. The clinical manifestations of a metabolic acidosis are nonspecific, and its differential diagnoses include common and rare diseases.

Approach for evaluating metabolic acidosis.

Approach for evaluating metabolic acidosis.

Approach for evaluating metabolic acidosis.

Approach for evaluating metabolic acidosis.

Pathophysiology

A primary metabolic acidosis is a pathophysiologic state characterized by an arterial pH less than 7.35 in the absence of an elevated PaCO2. It is created by one of three mechanisms: (1) increased production of acids, (2) decreased excretion of acids, or (3) loss of alkali.

Acutely, medullary chemoreceptors compensate for a metabolic acidosis through increases in alveolar ventilation. The resulting tachypnea and hyperpnea reduces the PaCO2 in an attempt to increase the pH back toward normal. In a primary metabolic acidosis, the degree of acute respiratory compensation can be predicted by the following relationship:

Expected PaCO2 = (1.5 X [HCO3 -]) + 8 ± 2

If the measured PaCO2 is higher than the expected PaCO2, a concomitant respiratory acidosis is also present. The development of normocapnia or hypercapnia when a severe metabolic acidosis is present often signals respiratory muscle fatigue, impending respiratory failure, and the possible need for initiating mechanical ventilation.

The kidneys are responsible for reclaiming filtered bicarbonate (HCO3 -) and eliminating the daily acid load generated from nitrogen (protein) metabolism. Normally, the kidneys excrete hydrogen ions (H+) through the formation of titratable acids and ammonium. The ability of the kidney to excrete an increased acid load generally begins 12-24 hours after the compensatory hyperventilation begins and continues for 1-3 days. Over time, the kidneys attempt to increase reabsorption of HCO3 - to compensate for the acidosis. The severity of the acidosis depends on the rapidity of bicarbonate loss and the ability of the kidney to replenish bicarbonate.

Anion gap

To achieve electrochemical balance, ionic elements in the extracellular fluid must equal a net charge of zero. Therefore, the number of negatively charged ions (anions) should equal the number of positively charged ions (cations). Measured serum anions are chloride and bicarbonate, and the unmeasured anions include phosphates, sulfates, and proteins (eg, albumin). The primary measured serum cation is sodium, but other cations are noted, such as calcium, potassium, and magnesium. Under typical conditions, unmeasured anions exceed unmeasured cations; this is referred to as the anion gap and can be represented by the following formulas:

(Chloride + Bicarbonate) + Unmeasured Anions = Sodium + Unmeasured Cations

Unmeasured Anions – Unmeasured Cations = Sodium – (Chloride + Bicarbonate)

Anion Gap = (Sodium) – (Chloride + Bicarbonate)

Practically, a metabolic acidosis is divided into processes that are associated with a normal anion gap (8-12 mEq/L) or an elevated anion gap (>12 mEq/L). A normal anion gap metabolic acidosis involves no gain of unmeasured anions; however, because of the need for electrical neutrality, serum chloride replaces the depleted bicarbonate, and hyperchloremia develops. In contrast, an elevated anion gap metabolic acidosis is caused when extra unmeasured anions are added to the blood.

General physiologic and metabolic effects

The clinical manifestations of a metabolic acidosis are related to the degree of acidemia. Initially, patients with a metabolic acidosis develop a compensatory tachypnea and hyperpnea; if the acidemia is severe, the child can present with significant work of breathing and distress. An increase in serum hydrogen ion concentration results in pulmonary vasoconstriction, which raises pulmonary artery pressure and pulmonary vascular resistance. An increase in right ventricular afterload and, potentially, right ventricular dysfunction can then occur. This is especially problematic in newborn infants with persistent pulmonary hypertension.

Tachycardia is the most common cardiovascular effect seen with a mild metabolic acidosis. As the serum pH continues to fall below 7.2, myocardial depression occurs because hydrogen ions act as a negative inotrope and peripheral vasodilation occurs. Also, with acidemia, cardiovascular response to endogenous and exogenous catecholamines can decrease, which can possibly exacerbate hypotension in children with volume depletion or shock.

CNS manifestations can include headache, lethargy, confusion, or any change in mental status secondary to a decrease in intracerebral pH. Cerebral vasodilation occurs as a result of a metabolic acidosis and may contribute to an increase in intracranial pressure.

During a metabolic acidosis, excess hydrogen ions move toward the intracellular compartment and potassium moves out of the cell into the extracellular space (serum). For every decrease in the serum pH by 0.1, a concomitant increase in the serum potassium level by 0.5 mEq occurs. As a result, hyperkalemic arrhythmias (peaked T waves and QRS widening) and ventricular fibrillation may occur. Other acute metabolic effects of acidemia include insulin resistance, increased protein degradation, and reduced ATP synthesis. During acidemia, the oxyhemoglobin dissociation curve shifts to the right; oxygen has a lower affinity for hemoglobin, but hemoglobin more readily releases oxygen. Also, nonspecific GI complaints, such as abdominal pain, nausea, or vomiting, may be present.

Frequency

United States

Metabolic acidosis is a biochemical derangement occurring as part of certain disease states and conditions. No statistics are available on its frequency.

Mortality/Morbidity

The underlying disorder usually produces most of the signs and symptoms in children with a mild or moderate metabolic acidosis. Untreated severe metabolic acidosis may be associated with life-threatening arrhythmias, myocardial depression, and respiratory muscle fatigue but is not the ultimate cause of morbidity and mortality.

Race

No racial predilection is noted.

Sex

The prevalence rates of metabolic acidosis are equal for males and females.

Age

Metabolic acidosis can occur in any age group.

Clinical

History

The etiology of a metabolic acidosis is often apparent from the history and physical examination. The following factors are assessed in a complete investigation of the patient's history:

  • Anorexia, nausea, vomiting, or diarrhea: In pediatric patients, diarrhea is the most common cause of a metabolic acidosis.
  • Metabolic acidosis associated with seizures, a depressed sensorium, or both in a neonate: This warrants consideration of an inborn error of metabolism, or neonatal sepsis.
  • History of depressed mental status, lethargy, and poor feeding in a neonate: Left-sided obstructive cardiac lesions should be considered (eg, aortic coarctation or hypoplastic left heart syndrome).
  • Failure to thrive suggestive of chronic metabolic acidosis: This can be seen in renal insufficiency or renal tubular acidosis (RTA).
  • New onset of polyuria, polydipsia, and weight loss: This could signify undiagnosed diabetes mellitus and diabetic ketoacidosis in a child.
  • Possible ingestion of a toxin or other form of intoxication: Inquire as to what medications are in the home. Suspect a poisoning in a healthy child who quickly develops a metabolic acidosis; possible agents are ethanol, ethylene glycol, salicylates, and methanol.
  • History of trauma, hives, or fever: Consider states associated with a lactic acidosis secondary to shock from hypovolemia, sepsis, cardiac failure, anaphylaxis, or spinal shock.
  • Chronic medical or surgical issue: Examples to be concerned with include chronic renal failure, presence of a ureterosigmoidostomy, or diabetes mellitus.

Physical

Clinical findings generally depend on the etiology and severity of the metabolic acidosis.

  • Hyperventilation or Kussmaul breathing may often be the first sign of a metabolic acidosis in a child. Breath sounds are often clear to auscultation (“quiet tachypnea”).
  • CNS manifestations may include lethargy, coma, and seizures.
  • Signs of dehydration may include tachycardia, dry mucous membranes, and delayed capillary refill.
  • Signs of a low cardiac output state may be weak pulses or cardiac gallop; an associated cardiovascular abnormality (eg, cardiomyopathy or left-sided cardiac lesion) may be present.

Causes

The causes of a metabolic acidosis can be classified on the basis of a normal or elevated anion gap.

  • An elevated anion gap is created by inorganic (eg, phosphate or sulfate), organic (eg, ketoacids or lactate), or exogenous (eg, salicylate) acids incompletely neutralized by bicarbonate. Frequent causes of an elevated anion gap metabolic acidosis is represented by the mnemonic MUDPILES:
    • Methanol
    • Uremia
    • Diabetic ketoacidosis
    • Paraldehyde
    • Iron, isoniazid (INH)
    • Lactic acid
    • Ethanol, ethylene glycol
    • Salicylates
  • A normal anion gap metabolic acidosis occurs when loss of bicarbonate from the GI tract or kidneys is excessive or when hydrogen ions cannot be secreted because of renal failure. The causes can be represented by the mnemonic USEDCARP:
    • Ureterostomy
    • Small bowel fistula
    • Extra chloride
    • Diarrhea
    • Carbonic anhydrase inhibitors (eg, acetazolamide)
    • Adrenal insufficiency
    • RTA
    • Pancreatic fistula
  • Infants are more likely to develop a normal anion gap metabolic acidosis secondary to significant losses of bicarbonate in diarrheal stools. The stool output can contain as much as 70-80 mEq/L of bicarbonate.
  • Patients with an ureterosigmoidostomy may lose bicarbonate in exchange for the reabsorption of chloride and ammonium as urine accumulates in the sigmoid colon.
  • Children with congenital or acquired renal tubular acidosis can lose large amounts of bicarbonate, with or without concomitant potassium loss.
  • Inborn errors of metabolism may result in a metabolic acidosis, with or without hypoglycemia or hyperammonemia.
  • In children, metabolic acidosis is frequently caused by lactate. Lactate is the end product of anaerobic glycolysis, which can be represented by the following equation:
      Glucose + 2 ATP + 2 H2 PO4 ® 2 Lactate + 2 ADP + 2 H2 O
  • Hydrogen ions generated by the hydrolysis of ATP converts lactate to lactic acid.
    • Under normal conditions, the liver rapidly converts these small amounts of lactic acid to pyruvic acid, which is then metabolized to carbon dioxide and water.
    • Under conditions of oxygen deprivation and decreased oxygen delivery to the tissues, anaerobic metabolism produces excessive amounts of lactic acid. Most disease processes that result in decreased oxygen delivery also frequently lead to diminished hepatic function, further compounding lactic acid accumulation.
    • Conditions that frequently lead to lactic acidosis include shock, sepsis, thiamine deficiency, diabetic ketoacidosis, and cellular poisoning (eg, cyanide toxicity).

More on Acidosis, Metabolic

Overview: Acidosis, Metabolic
Differential Diagnoses & Workup: Acidosis, Metabolic
Treatment & Medication: Acidosis, Metabolic
Follow-up: Acidosis, Metabolic
Multimedia: Acidosis, Metabolic
References

References

  1. Glaser N, Barnett P, McCaslin I, et al. Risk factors for cerebral edema in children with diabetic ketoacidosis. The Pediatric Emergency Medicine Collaborative Research Committee of the American Academy of Pediatrics. N Engl J Med. Jan 25 2001;344(4):264-9. [Medline].

  2. Han JJ, Yim HE, Lee JH, et al. Albumin versus normal saline for dehydrated term infants with metabolic acidosis due to acute diarrhea. J Perinatol. Jun 2009;29(6):444-7. [Medline].

  3. [Guideline] Hodson E. Metabolic acidosis and growth in children. Nephrology. Dec 2005;10(S5):S221-2. [Full Text].

  4. Casaletto JJ. Differential diagnosis of metabolic acidosis. Emerg Med Clin North Am. Aug 2005;23(3):771-87, ix. [Medline].

  5. Fall PJ. A stepwise approach to acid-base disorders. Practical patient evaluation for metabolic acidosis and other conditions. Postgrad Med. Mar 2000;107(3):249-50, 253-4, 257-8 passim. [Medline].

  6. Fattal-Valevski A, Kesler A, Sela BA, et al. Outbreak of life-threatening thiamine deficiency in infants in Israel caused by a defective soy-based formula. Pediatrics. Feb 2005;115(2):e233-8. [Medline].

  7. Levraut J, Grimaud D. Treatment of metabolic acidosis. Curr Opin Crit Care. Aug 2003;9(4):260-5. [Medline].

  8. Naka T, Bellomo R. Bench-to-bedside review: treating acid-base abnormalities in the intensive care unit--the role of renal replacement therapy. Crit Care. Apr 2004;8(2):108-14. [Medline].

  9. Szaflarski N, Hanson CW 3rd. Metabolic acidosis. AACN Clin Issues. Aug 1997;8(3):481-96. [Medline].

  10. Thauvin-Robinet C, Faivre L, Barbier ML, Chevret L, Bourgeois J, Netter JC. Severe lactic acidosis and acute thiamin deficiency: a report of 11 neonates with unsupplemented total parenteral nutrition. J Inherit Metab Dis. 2004;27(5):700-4. [Medline].

  11. Uchida H, Yamamoto H, Kisaki Y, Fujino J, Ishimaru Y, Ikeda H. D-lactic acidosis in short-bowel syndrome managed with antibiotics and probiotics. J Pediatr Surg. Apr 2004;39(4):634-6. [Medline].

Further Reading

Keywords

metabolic acidosis, bicarbonate, anions, cations, hydrogen, anion gap, anion gap acidosis, normal anion gap metabolic acidosis, renal tubular acidosis, RTA, acid-base disorder, plasma bicarbonate, plasma bicarbonate level, acidemia, respiratory acidosis, respiratory failure, myocardial depression, diarrhea, inborn error of metabolism, neonatal sepsis, hypoplastic left heart syndrome, renal insufficiency, renal tubular acidosis, RTA, failure to thrive, hypoglycemia, hyperammonemia, treatment, diagnosis

Contributor Information and Disclosures

Author

Margaret A Priestley, MD, Assistant Professor of Clinical Anesthesiology and Critical Care, University of Pennsylvania School of Medicine; Clinical Director, Pediatric Intensive Care Unit, The Children's Hospital of Philadelphia
Margaret A Priestley, MD is a member of the following medical societies: American Academy of Pediatrics, American Medical Association, and Society of Critical Care Medicine
Disclosure: Nothing to disclose.

Medical Editor

G Patricia Cantwell, MD, Associate Clinical Professor, Department of Pediatrics, University of Miami; Director of Pediatric Critical Care Medicine, Miller School of Medicine, Jackson Children's Hospital
G Patricia Cantwell, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Emergency Physicians, American Heart Association, American Trauma Society, National Association of EMS Physicians, Society of Critical Care Medicine, and Wilderness Medical Society
Disclosure: Nothing to disclose.

Pharmacy Editor

Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine
Disclosure: Pfizer Inc Stock Investment from financial planner; Avanir Pharma Stock Investment from financial planner ; WebMD Salary and stock Employment and investment from financial planner

Managing Editor

Barry J Evans, MD, Assistant Professor of Pediatrics, Temple University Medical School; Director of Pediatric Critical Care and Pulmonology, Associate Chair for Pediatric Education, Temple University Children's Medical Center
Barry J Evans, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Chest Physicians, American Thoracic Society, and Society of Critical Care Medicine
Disclosure: Nothing to disclose.

CME Editor

Mary E Cataletto, MD, Associate Director, Division of Pediatric Pulmonology, Winthrop University Hospital; Professor of Clinical Pediatrics, State University of New York at Stony Brook; Director of Children's Sleep Services, Winthrop University Hospital
Mary E Cataletto, MD is a member of the following medical societies: American Academy of Pediatrics and American College of Chest Physicians
Disclosure: Shering Plough Pharmaceuticals Honoraria Consulting

Chief Editor

Timothy E Corden, MD, Associate Professor of Pediatrics, Co-Director, Policy Core, Injury Research Center, Medical College of Wisconsin; Associate Director, PICU, Children's Hospital of Wisconsin
Timothy E Corden, MD is a member of the following medical societies: American Academy of Pediatrics, Phi Beta Kappa, Society of Critical Care Medicine, and Wisconsin Medical Society
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.